About the TheraBionic P1 device

May 30, 2024 | Oncology

Dr. Boris Pasche, MD, PhD explains how the TheraBionic P1 medical device works to treat cancer. The TheraBionic P1 device is currently FDA approved for treatment of adult patients with advanced hepatocellular carcinoma (HCC), the most common form of liver cancer, for whom 1st and 2nd line therapies have failed.